April 24 2024, David R Brown
IMCD Spain expands its pharmaceuticals presence with the acquisition of Cobapharma
IMCD N.V., a leading global distributor of speciality chemicals and ingredients, has announced that its Spainish subsidiary, IMCD España Especialidades Químicas S.A., has signed an agreement to acquire 100% of the shares in Cobapharma, S.L.U, a European distributor operating in the pharmaceutical and nutraceutical industry.
Cobopharma's reputation for providing high-quality APIs and nutraceutical ingredients perfectly complements our existing portfolio
John Robinson
Business Group Director IMCD Pharmaceuticals
Established in 2011 and headquartered in Barcelona, Spain, Cobapharma provides an extensive portfolio of Active Pharmaceutical Ingredients (APIs) as well as nutraceutical ingredients. With 20 employees, Cobapharma represents leading suppliers and generated a revenue of approximately EUR 19 million in 2023.
“Cobapharma is a rapidly growing distributor in the pharmaceutical and nutraceutical industry. Their esteemed reputation for providing high-quality APIs and nutraceutical ingredients perfectly complements our existing portfolio. The alignment of our business models will enhance our ability to serve our customers and partners”, commented John Robinson, Business Group Director IMCD Pharmaceuticals.
“We are excited to join IMCD. This acquisition opens new opportunities for Cobapharma to expand its offerings and reach a broader customer base. We look forward to leveraging IMCD's expertise and network to accelerate our growth and value creation to our customers”, added Gianluca Galimberti, General Manager Cobapharma.
The closing of the transaction is subject to customary (regulatory) closing conditions and is expected to take place in the second quarter of 2024.
About IMCD N.V.
IMCD is a market-leader in the sales, marketing, and distribution of speciality chemicals and ingredients. Its result-driven professionals provide market-focused solutions to suppliers and customers across EMEA, Americas and Asia-Pacific, offering a range of comprehensive product portfolios, including innovative formulations that embrace industry trends.
Listed at Euronext, Amsterdam (IMCD), IMCD realised revenues of EUR 4,442.6 million in 2023 with nearly 4,736 employees in over 60 countries, working from 116 offices spanning 6 continents. IMCD's dedicated team of technical and commercial experts work in close partnership to tailor best-in-class solutions and provide value through expertise for around 60,000 plus customers and a diverse range of world class suppliers.
Source(s): IMCD Press Release
Further Information
Visit: https://www.imcdgroup.com